From Only 5% of the Manufacturer Lots According to VAERS Comes 100% of Deaths Comments by Brian Shilhavy, Editor, Health Impact News
They used a batch number analysis from the influenza vaccines for a “control dataset” to determine what is typical of percentage of adverse reactions spread across all batches.
Not only was this analysis shocking in finding that total deaths were concentrated in only 5% of the batches manufactured, they also found that the data showed that this 5% of total batches produced were also the more widely distributed batches to all 50 states.
This raises many ethical and potentially criminal questions. Are we just dealing with quality control issues here, or something more evil by these pharmaceutical companies, most of which have long rap sheets of criminal activities in their past, particularly Pfizer?
We do know, for example, that certain documents that Pfizer supplied to the European Medicines Agency (EMA) for their COVID-19 shots showed that in some of the test batches they only had 55% of the mRNA intact. (Source.)
The EMA allegedly approved the shots anyway because “the amounts of a potential protein produced by the truncated mRNA would be too low to constitute a safety risk.” (Source.)
That should equate to fewer, not more, adverse reactions like deaths recorded in VAERS.
This would mean that the greater percentage of batches produced, but also the fewest distributed and with the fewest amounts of adverse reactions, are the faulty ones not produced properly, while the 5% of the ones causing the most harm and distributed the most are doing exactly what they were manufactured to do.
We are publishing the analysis by The